CEO Matthew Weinberg Presents at FDA Clinical Trials Hearing

  • April 23, 2012

April 23 – The Weinberg Group CEO, Matthew Weinberg, presented today at FDA’s hearing titled “Modernizing the Regulation of Clinical Trials and Approaches to Good Clinical Practice.”  Mr. Weinberg presented on the mandatory need for audits and audit independence.  A full copy of his presentation can be found below.

For more information on The Weinberg Group’s independent clinical auditing services, please contact
Jeff Antos, Vice President, at or 202.280.0815.